Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" AFDN "AF-6, AF6, MLLT4" ENSG00000130396 "Afadin, adherens junction formation factor" P55196 6 167826922-167972023 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Cell adhesion" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 157.8;Alveolar cells type 2: 72.9;Ciliated cells: 85.6;Club cells: 75.1;Collecting duct cells: 90.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013496, HPA030212, HPA030213, HPA030214, HPA030215, HPA049868" Approved Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "CAB013496: , HPA030212: AB_10599291, HPA030213: AB_10601340, HPA030214: AB_10601005, HPA030215: AB_10601556, HPA049868: AB_2680924" "prognostic unfavorable (7.43e-5)" "unprognostic (2.66e-3)" "unprognostic (2.07e-2)" "unprognostic (2.61e-1)" "unprognostic (1.13e-1)" "unprognostic (9.06e-2)" "unprognostic (4.12e-1)" "unprognostic (3.12e-2)" "unprognostic (4.12e-1)" "unprognostic (1.09e-3)" "unprognostic (1.75e-1)" "unprognostic (1.73e-2)" "unprognostic (5.56e-2)" "unprognostic (5.43e-3)" "unprognostic (1.59e-1)" "unprognostic (4.72e-2)" "unprognostic (5.68e-2)" 17.0 7.4 14.9 13.0 17.2 1.8 23.5 17.8 19.3 19.6 26.3 16.1 25.5 22.2 15.8 17.7 59.5 27.9 18.2 13.9 15.6 7.2 20.6 29.3 26.3 5.1 17.1 12.5 16.2 29.7 16.4 27.4 18.7 16.1 20.9 27.2 15.3 38.6 18.6 12.7 24.8 42.3 17.4 13.0 13.5 21.1 16.3 15.2 2.1 25.7 13.7 24.5 16.3 27.9 3.5 0.6 2.9 0.5 0.0 1.2 0.0 18.9 5.9 41.5 14.8 4.0 3.4 30.9 7.7 4.0 6.7 8.3 25.3 11.9 3.4 14.3 4.6 10.5 9.1 17.2 15.8 12.0 21.4 17.8 0.1 2.5 19.1 6.1 2.1 9.1 2.4 10.7 11.2 26.5 10.7 12.3 7.4 38.0 13.3 4.3 8.1 0.2 0.1 10.1 27.1 2.7 12.3 10.9 14.4 12.2 9.3 19.2 11.7 7.8 29.8 11.8 40.5 3.5 0.8 18.0 3.1 15.1 13.4 12.7 0.2 16.1 6.9 9.3 4.4 27.2 0.0 0.5 0.0 1.0 0.5 0.6 3.5 1.2 0.4 0.6 2.7 0.0 0.5 2.9 0.0 0.3 0.0 0.6 0.0 14.9 17.2 17.8 19.3 15.6 7.2 17.1 12.5 16.1 15.2 157.8 72.9 0.0 0.0 0.0 0.0 0.0 0.0 85.6 75.1 90.7 0.0 27.0 18.3 58.2 0.0 0.0 0.0 0.0 34.2 28.5 0.0 0.0 8.1 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 19.0 0.0 0.0 52.1 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 35.2 0.0 0.0 0.0 ARVCF ENSG00000099889 "ARVCF, delta catenin family member" O00192 22 19969896-20016808 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 30.8" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 21.6;Muller glia cells: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "K-562: 15.7;SCLC-21H: 15.0;SH-SY5Y: 11.5;U-2 OS: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016162, HPA055264, HPA063675" Enhanced Enhanced "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "CAB016162: AB_2058690, HPA055264: AB_2682766, HPA063675: AB_2685085" "unprognostic (1.66e-1)" "unprognostic (1.48e-2)" "unprognostic (4.00e-2)" "unprognostic (4.28e-2)" "unprognostic (3.35e-1)" "unprognostic (3.18e-2)" "unprognostic (4.79e-3)" "unprognostic (1.67e-2)" "unprognostic (2.06e-2)" "unprognostic (1.71e-2)" "unprognostic (2.09e-3)" "unprognostic (5.77e-2)" "unprognostic (4.00e-3)" "unprognostic (9.84e-2)" "unprognostic (1.56e-1)" "unprognostic (1.15e-1)" "prognostic favorable (5.76e-6)" 3.4 6.6 9.0 1.8 6.1 6.0 3.2 30.8 11.1 3.4 3.2 7.7 3.5 2.7 4.2 14.6 3.1 2.6 8.0 6.2 8.1 8.1 5.0 4.9 3.9 1.4 3.8 6.8 2.9 8.7 4.9 7.3 2.7 5.9 6.1 1.1 6.4 8.7 4.6 13.4 5.3 3.7 3.6 4.0 13.4 5.2 5.2 2.8 0.5 12.1 1.6 1.5 2.8 1.8 0.0 0.6 0.0 0.2 0.7 1.2 0.8 3.3 0.3 4.5 5.9 0.0 0.0 4.7 0.8 0.3 0.2 0.5 0.9 0.7 1.4 3.7 0.4 0.4 3.1 0.7 1.4 0.0 0.4 5.6 0.4 0.3 3.5 1.3 0.5 1.1 0.1 0.6 0.2 0.2 0.3 3.7 1.0 15.7 0.4 0.0 3.0 0.2 2.1 4.6 1.0 1.8 8.3 0.2 0.4 0.8 0.7 15.0 11.5 0.9 1.4 2.2 0.8 1.2 0.4 1.3 0.1 13.1 0.5 0.3 1.8 0.5 0.4 0.2 0.2 0.2 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.4 1.2 0.0 0.7 0.0 0.6 0.0 0.8 9.0 6.1 30.8 8.9 8.1 8.1 3.8 6.8 5.9 2.8 3.0 1.6 0.0 2.6 1.8 8.5 5.0 5.1 1.4 0.0 1.8 21.6 3.8 0.0 7.0 2.1 1.6 1.2 0.0 4.6 1.7 1.9 4.2 0.0 3.2 1.2 4.8 8.6 4.3 1.0 1.3 3.7 0.9 3.3 0.0 6.2 18.8 9.7 0.0 3.2 5.0 7.6 0.0 3.1 2.2 9.2 1.6 3.7 0.0 1.8 0.9 C11orf52 "FLJ25219, MGC14839" ENSG00000149300 "Chromosome 11 open reading frame 52" Q96A22 11 111918032-111926872 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 3.2;Ciliated cells: 10.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 8.5;CAPAN-2: 11.1;Hep G2: 9.4;MCF7: 8.4;RPTEC TERT1: 13.7;SK-BR-3: 11.7;T-47d: 38.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA038387, HPA038388" Uncertain Enhanced "Cell Junctions" NA NA "Cell Junctions" "HPA038387: AB_10670167, HPA038388: AB_2675987" "unprognostic (1.30e-2)" "unprognostic (1.13e-1)" "unprognostic (5.84e-4)" "unprognostic (1.48e-4)" "unprognostic (2.57e-1)" "unprognostic (8.04e-2)" "unprognostic (6.77e-2)" "unprognostic (2.07e-2)" "unprognostic (2.26e-1)" "unprognostic (2.77e-1)" "unprognostic (3.80e-1)" "unprognostic (5.38e-4)" "unprognostic (1.44e-1)" "unprognostic (1.84e-1)" "unprognostic (3.03e-1)" 1.8 0.5 0.7 1.0 1.9 0.0 13.8 3.2 0.8 1.7 7.6 0.9 25.9 4.9 2.1 12.8 3.9 8.9 11.3 2.0 1.0 0.6 38.7 12.9 12.7 0.3 2.9 0.3 2.2 38.0 12.6 12.8 25.8 2.2 9.1 2.9 1.6 23.8 33.9 5.3 5.5 12.4 1.0 2.5 0.6 10.9 0.8 1.0 0.8 22.9 2.1 3.0 4.6 3.6 0.0 0.0 0.0 0.1 0.0 0.7 0.0 2.1 0.0 0.0 0.0 1.4 0.2 8.5 0.5 0.4 0.1 0.0 3.2 11.1 0.0 5.2 1.2 0.0 2.6 0.0 0.7 0.0 0.0 0.3 0.0 0.2 9.4 0.0 0.0 0.0 0.3 2.6 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.7 8.4 0.0 0.0 0.0 5.8 0.9 0.0 0.7 0.0 13.7 7.5 0.5 0.0 0.0 11.7 0.0 1.2 38.4 0.7 0.9 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.9 3.2 0.8 1.0 0.6 2.9 0.3 2.2 1.0 6.0 3.2 0.0 0.7 0.1 0.0 0.4 0.0 10.7 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.1 0.3 1.1 0.0 0.0 0.5 CTNNA1 CAP102 ENSG00000044115 "Catenin alpha 1" P35221 5 138610967-138935034 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021089, HPA046119, HPA063535" Approved Enhanced "Plasma membrane,Cell Junctions" NA NA 5400 "Plasma membrane, Cell Junctions" "CAB021089: AB_10123543, HPA046119: AB_2679547, HPA063535: AB_2685033" "unprognostic (2.25e-3)" "unprognostic (3.32e-2)" "unprognostic (2.82e-3)" "unprognostic (1.80e-1)" "unprognostic (8.40e-2)" "unprognostic (2.35e-1)" "unprognostic (1.66e-3)" "unprognostic (4.83e-2)" "unprognostic (2.28e-1)" "unprognostic (2.48e-1)" "prognostic unfavorable (8.02e-4)" "unprognostic (6.18e-2)" "prognostic favorable (7.34e-7)" "unprognostic (1.54e-1)" "unprognostic (2.31e-1)" "unprognostic (7.62e-2)" "unprognostic (1.04e-1)" 55.9 54.0 39.6 24.4 50.2 10.9 55.1 16.5 39.5 43.4 58.9 68.5 33.9 44.2 53.0 47.5 76.9 45.8 41.1 68.6 38.8 32.3 62.2 37.7 49.8 27.0 57.3 29.3 42.7 38.1 55.5 25.6 54.0 45.5 39.4 49.0 35.6 48.8 43.5 30.5 49.8 53.9 59.6 49.7 30.9 48.2 18.7 56.6 8.1 51.2 46.4 44.1 48.4 45.1 3.8 15.2 9.8 21.8 0.3 5.0 7.1 32.2 23.5 35.7 52.8 31.1 34.2 54.4 32.7 41.2 31.3 39.7 49.0 43.9 0.1 27.7 48.8 34.4 24.7 24.5 53.8 36.5 18.5 21.3 13.6 38.8 29.7 37.5 0.2 13.3 21.5 43.1 37.4 41.1 34.9 59.0 9.8 7.4 14.0 33.7 28.5 0.3 4.1 14.3 34.4 0.5 12.7 20.8 19.4 66.1 43.2 14.3 18.8 60.4 84.9 49.4 79.5 30.0 9.3 50.0 33.0 17.9 20.4 22.6 5.1 9.5 1.9 31.4 5.9 42.5 2.2 17.1 1.5 2.9 21.8 1.9 3.8 2.1 2.1 15.2 3.2 0.1 1.1 9.8 0.3 20.2 3.7 5.0 7.1 39.6 50.2 16.5 39.5 38.8 32.3 57.3 29.3 45.5 56.6 241.2 121.7 23.1 99.7 69.7 8.7 202.9 84.1 172.6 201.3 115.1 19.6 101.5 58.0 167.3 13.9 111.5 204.4 23.3 152.7 117.7 74.1 118.0 39.3 51.3 79.8 3.2 49.0 92.7 73.9 18.8 72.2 73.0 74.2 212.8 129.6 45.5 232.1 131.5 79.5 116.5 23.0 97.0 108.1 17.0 21.1 67.5 158.8 17.0 92.7 143.6 CXADR CAR ENSG00000154639 "CXADR, Ig-like cell adhesion molecule" P78310 21 17512382-17593579 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 41.4" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 287.2;Suprabasal keratinocytes: 300.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 32.2;Hep G2: 20.8;NTERA-2: 37.3;RT4: 36.0" "HPA003342, CAB005103, HPA030411, HPA030412" Enhanced Enhanced "Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA 11000 "Plasma membrane, Cell Junctions" "CAB005103: AB_2087557, HPA003342: AB_1078588, HPA030411: AB_10599620, HPA030412: AB_10601992" "unprognostic (3.75e-1)" "unprognostic (1.03e-1)" "unprognostic (6.45e-3)" "unprognostic (2.10e-1)" "unprognostic (1.56e-1)" "prognostic favorable (3.50e-4)" "unprognostic (1.32e-1)" "unprognostic (2.52e-1)" "unprognostic (1.94e-1)" "unprognostic (2.15e-1)" "unprognostic (3.48e-3)" "unprognostic (1.04e-1)" "unprognostic (9.35e-2)" "unprognostic (3.89e-3)" "unprognostic (2.20e-1)" "unprognostic (8.27e-2)" "unprognostic (5.71e-3)" 4.0 3.1 6.4 3.2 9.4 1.3 5.8 2.0 15.4 6.3 27.1 12.5 9.0 24.9 3.3 9.3 15.0 6.5 17.2 10.8 7.9 5.5 5.1 28.6 9.9 4.2 9.2 5.6 1.1 12.0 5.2 11.1 0.3 11.6 9.2 15.4 3.7 16.3 15.8 0.6 30.0 41.4 2.1 13.0 1.4 17.6 8.5 6.9 0.9 13.1 4.9 3.8 14.7 10.0 0.8 0.4 2.6 0.5 0.9 2.7 0.9 5.6 3.1 15.4 0.0 0.0 0.0 9.3 0.0 0.0 0.2 0.9 32.2 4.9 2.0 6.9 0.0 4.6 9.8 7.8 2.0 0.3 3.1 6.6 0.0 9.2 20.8 1.0 0.6 0.0 0.0 8.5 0.4 0.1 3.7 3.0 1.9 0.1 0.1 0.0 0.3 1.2 0.0 37.3 5.0 0.0 0.0 5.2 4.0 12.9 36.0 6.2 4.2 3.6 4.1 2.1 16.5 8.6 0.1 0.1 0.0 9.3 0.1 2.2 1.5 2.5 0.1 1.2 0.0 0.2 2.6 0.5 0.4 0.5 0.2 1.0 0.3 2.6 0.6 0.1 0.8 2.7 0.8 1.4 0.9 0.2 0.4 0.5 0.9 6.4 9.4 2.0 15.4 7.9 5.5 9.2 5.6 11.6 6.9 131.0 63.6 1.5 156.7 287.2 15.2 27.4 137.6 50.9 55.7 97.7 25.5 1.0 5.0 109.2 4.3 2.0 199.0 0.0 81.3 0.2 6.8 133.1 5.7 114.1 0.6 0.0 77.6 70.6 23.6 4.0 2.0 5.3 21.9 1.0 96.0 11.6 81.7 112.0 0.0 4.4 10.0 6.5 3.8 4.2 22.3 300.5 0.6 3.8 81.0 165.3 DSC3 "CDHF3, DSC, DSC1, DSC2, DSC4" ENSG00000134762 "Desmocollin 3" Q14574 18 30990008-31042815 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" Hypotrichosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 73.2;lymphoid tissue: 28.4;skin 1: 99.1;tongue: 92.4" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 444.8;Suprabasal keratinocytes: 602.1" "Cancer enhanced" "Detected in many" "cervical cancer: 78.6;head and neck cancer: 107.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 71.0;HBEC3-KT: 16.3;hTCEpi: 42.0;hTERT-HME1: 30.9;REH: 11.9" "Group enriched" "Detected in some" 4 "basal ganglia: 1.3;hippocampal formation: 3.6" "Low region specificity" "Detected in some" "CAB037328, HPA049265, HPA073937" Enhanced Enhanced "Plasma membrane,Cell Junctions" NA NA 2700000 "Plasma membrane, Cell Junctions" "CAB037328: , HPA049265: AB_2680695, HPA073937: AB_2686645" "unprognostic (4.44e-3)" "unprognostic (6.28e-2)" "unprognostic (1.46e-1)" "unprognostic (3.02e-3)" "unprognostic (2.38e-1)" "unprognostic (1.32e-2)" "unprognostic (6.38e-2)" "unprognostic (1.84e-2)" "unprognostic (2.41e-1)" "unprognostic (3.48e-2)" "unprognostic (3.92e-3)" "unprognostic (3.13e-1)" "unprognostic (4.13e-4)" "unprognostic (1.22e-2)" "unprognostic (7.85e-2)" "unprognostic (3.47e-1)" "prognostic unfavorable (1.04e-5)" 1.5 0.0 0.0 0.6 0.0 0.0 10.4 0.0 0.0 11.9 1.0 0.0 0.4 0.1 2.1 1.4 73.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.0 2.4 0.1 16.0 0.1 4.5 0.0 0.0 7.2 0.3 0.2 99.1 0.2 0.1 0.0 0.0 0.0 0.5 0.0 2.2 0.0 92.4 28.4 1.0 14.4 0.7 0.2 1.0 0.5 0.4 0.4 0.1 4.5 0.5 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 71.0 0.0 16.3 0.0 0.0 3.9 0.2 1.4 0.1 2.7 0.0 0.0 2.8 42.0 0.0 30.9 5.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 5.8 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.2 0.3 0.2 0.2 0.4 0.3 0.2 0.0 0.7 0.3 0.4 1.0 0.4 0.5 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.0 1.4 0.0 43.5 444.8 0.0 1.2 0.0 2.7 19.4 0.0 0.0 62.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 10.1 7.5 19.6 0.0 0.0 4.6 0.0 2.4 0.0 0.0 0.0 0.0 0.6 37.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 602.1 20.9 0.0 0.0 96.7 EGFR "ERBB, ERBB1" ENSG00000146648 "Epidermal growth factor receptor" P00533 7 55019021-55211628 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Host-virus interaction" "Developmental protein, Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 102.3" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 207.2;Syncytiotrophoblasts: 315.1" "Cancer enhanced" "Detected in all" "glioma: 136.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 12 "A-431: 345.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB000035, HPA001200, HPA018530, CAB068186, CAB073534" Enhanced Enhanced "Plasma membrane,Cell Junctions" "Secreted to blood" NA NA 4740000 93000000 "Plasma membrane, Cell Junctions" "CAB000035: , CAB068186: AB_2665679, CAB073534: , HPA001200: AB_1078723, HPA018530: AB_1848044" "unprognostic (2.62e-2)" "unprognostic (9.56e-3)" "unprognostic (1.59e-1)" "unprognostic (7.51e-2)" "unprognostic (1.08e-1)" "unprognostic (1.27e-2)" "unprognostic (6.11e-2)" "unprognostic (4.88e-2)" "unprognostic (2.85e-2)" "unprognostic (3.30e-3)" "unprognostic (1.78e-3)" "unprognostic (1.04e-1)" "unprognostic (1.93e-3)" "unprognostic (6.98e-3)" "unprognostic (1.72e-1)" "unprognostic (6.62e-2)" "prognostic unfavorable (2.04e-5)" 16.2 8.4 4.9 7.5 6.8 0.1 39.8 5.1 8.5 13.8 7.8 3.3 10.7 3.6 8.2 11.7 15.6 8.8 8.5 4.8 6.8 2.7 7.6 23.5 14.2 2.3 4.1 3.9 10.4 10.1 1.8 2.1 102.3 5.6 10.9 6.7 9.2 15.4 12.9 10.7 32.5 6.3 15.5 3.5 3.3 7.8 5.5 5.9 3.2 12.8 15.5 8.0 10.2 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 345.9 4.4 1.1 1.5 7.1 4.4 1.2 3.4 4.6 2.1 1.6 0.8 3.7 0.2 0.8 2.9 9.0 13.9 0.0 15.3 2.5 0.1 0.2 0.0 1.9 0.2 1.8 0.0 0.0 2.1 14.0 5.3 28.6 3.1 0.2 0.0 0.0 0.0 4.5 0.2 0.0 0.0 0.3 1.3 2.2 0.0 0.6 0.0 2.6 3.7 0.0 1.3 2.9 3.5 0.7 1.2 0.3 0.8 1.0 1.9 0.5 14.9 3.2 0.0 0.3 0.2 2.6 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 6.8 5.1 6.6 6.8 2.7 4.1 3.9 5.6 5.9 89.3 37.5 4.2 67.7 76.2 1.5 7.3 53.5 16.0 59.1 21.0 5.9 207.2 0.0 30.6 4.6 10.9 15.9 23.3 21.0 36.6 45.3 37.8 0.0 77.4 24.2 0.0 4.1 6.7 7.0 2.2 118.8 1.3 16.9 2.8 25.3 106.1 41.7 17.3 125.5 14.0 2.3 77.6 23.1 1.6 2.7 78.5 315.1 0.0 20.0 46.4 EPB41L3 "4.1B, DAL1, KIAA0987" ENSG00000082397 "Erythrocyte membrane protein band 4.1 like 3" Q9Y2J2 18 5392381-5630700 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis Actin-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.8" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 163.9;Late spermatids: 207.6;Syncytiotrophoblasts: 179.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 7.7;non-classical monocyte: 11.6" "Lineage enriched" "Detected in many" 4 "monocytes: 11.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 20.9;HUVEC TERT2: 18.9;SCLC-21H: 21.2;TIME: 51.8;U-2 OS: 18.9;U-2197: 18.4;U-251 MG: 22.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028605 Enhanced Enhanced "Plasma membrane,Cell Junctions" NA NA 140000 "Plasma membrane, Cell Junctions" "HPA028605: AB_10611963" "unprognostic (3.58e-3)" "unprognostic (1.17e-2)" "unprognostic (3.61e-1)" "unprognostic (7.97e-2)" "unprognostic (1.88e-1)" "unprognostic (1.44e-2)" "unprognostic (2.60e-1)" "unprognostic (9.73e-2)" "unprognostic (3.40e-1)" "unprognostic (3.63e-3)" "unprognostic (1.07e-3)" "unprognostic (5.81e-2)" "unprognostic (5.96e-2)" "unprognostic (5.65e-3)" "unprognostic (8.99e-2)" "unprognostic (2.72e-2)" "unprognostic (6.59e-3)" 17.1 19.4 12.0 16.4 32.1 2.5 8.9 35.9 36.3 5.1 10.6 36.2 1.4 29.8 5.8 7.1 6.8 8.8 6.0 6.0 11.3 16.6 21.0 3.1 8.8 8.8 46.4 15.9 7.8 4.4 14.7 9.0 12.7 46.8 4.0 8.4 3.8 3.6 5.0 4.6 3.5 27.9 8.3 27.2 10.5 3.2 35.9 36.6 0.9 4.0 1.5 2.6 5.6 5.8 0.0 2.5 0.7 11.6 0.0 0.6 0.7 0.1 0.3 1.2 0.0 17.9 20.9 14.1 4.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 12.4 7.5 0.0 12.2 0.0 0.0 0.0 10.9 0.0 0.1 0.0 0.0 0.0 1.4 10.9 0.0 3.9 0.0 5.2 18.9 0.0 0.1 0.1 0.0 0.0 0.1 0.2 2.5 0.0 4.0 0.0 0.0 0.0 0.1 1.5 21.2 0.1 0.0 0.1 8.3 10.5 0.2 1.5 51.8 0.1 18.9 18.4 22.2 0.0 0.0 0.0 0.0 1.7 2.1 0.0 4.5 0.0 0.0 7.7 0.0 0.0 0.0 0.0 2.5 0.0 0.6 0.0 0.7 0.0 11.6 0.0 0.0 0.7 12.0 32.1 35.9 27.7 11.3 16.6 46.4 15.9 46.8 36.6 17.9 8.3 0.0 3.7 14.2 75.0 2.0 5.1 2.7 3.4 7.0 72.6 84.0 13.3 0.3 163.9 11.1 47.9 0.0 0.6 44.2 10.4 3.0 0.0 0.5 50.4 3.2 8.7 3.7 66.5 207.6 20.8 56.6 10.1 55.9 6.1 2.9 1.2 7.0 7.4 56.6 13.2 0.0 5.0 1.9 3.0 7.3 179.0 2.2 7.2 1.3 FBLIM1 "CAL, FBLP-1, migfilin" ENSG00000162458 "Filamin binding LIM protein 1" Q8WUP2 1 15756607-15786594 "Predicted intracellular proteins" "Cell adhesion, Cell shape" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Peritubular cells: 180.0;Sertoli cells: 142.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 54.1;TIME: 84.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA025287, HPA072750" Approved Enhanced "Nucleoli fibrillar center,Cell Junctions,Focal adhesion sites" NA NA "Cell Junctions, Focal adhesion sites" "Nucleoli fibrillar center" "HPA025287: AB_1848443, HPA072750: AB_2686554" "unprognostic (4.10e-2)" "prognostic unfavorable (4.07e-4)" "unprognostic (2.26e-1)" "unprognostic (5.33e-2)" "unprognostic (2.46e-2)" "unprognostic (1.52e-1)" "unprognostic (9.33e-2)" "unprognostic (8.77e-3)" "prognostic unfavorable (6.15e-4)" "unprognostic (2.02e-1)" "unprognostic (1.67e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (8.64e-4)" "unprognostic (8.33e-2)" "unprognostic (3.01e-1)" "unprognostic (1.08e-1)" "unprognostic (8.21e-2)" 11.6 6.0 1.7 12.8 1.4 0.0 10.1 0.8 1.3 21.5 36.6 1.4 26.8 24.6 30.3 15.8 17.8 16.5 60.2 21.7 1.2 1.0 18.2 3.0 14.7 16.1 1.8 1.6 36.0 13.0 13.9 3.8 21.5 2.3 26.7 15.7 9.0 13.0 26.5 4.1 6.2 62.8 18.7 1.3 22.7 18.9 22.3 0.9 1.3 10.3 7.4 6.3 24.7 16.9 1.8 1.3 4.6 1.2 1.6 1.2 0.3 6.5 3.7 3.3 0.1 0.8 1.7 4.5 11.2 17.9 8.3 6.7 1.2 9.9 0.0 24.3 18.0 14.4 12.7 2.4 25.7 4.1 0.0 1.2 0.0 0.9 6.3 21.6 0.0 0.1 8.5 17.2 6.9 16.5 17.2 54.1 0.4 0.2 1.6 2.8 0.1 0.1 0.1 3.4 10.3 4.8 0.0 0.0 0.2 10.4 4.5 0.0 8.0 5.9 0.7 1.3 7.2 1.4 0.1 84.4 11.0 1.5 0.1 5.1 0.1 0.2 0.1 1.6 0.0 0.1 4.6 1.2 1.0 0.7 0.5 0.6 1.0 0.7 0.7 0.4 1.8 1.1 1.2 3.5 1.6 0.7 1.3 0.4 0.3 1.7 1.4 0.8 1.3 1.2 1.0 1.8 1.6 2.3 0.9 11.9 21.5 5.2 54.8 76.6 3.5 30.9 45.9 12.0 29.6 15.7 5.9 5.8 0.0 80.2 2.4 18.4 138.3 0.0 46.9 102.1 26.9 24.2 17.4 1.8 5.3 1.6 44.1 38.1 0.6 1.8 74.2 10.4 13.5 3.6 47.1 10.0 88.8 84.2 180.0 1.2 5.1 142.3 66.2 2.3 1.8 54.8 16.2 6.1 40.4 47.2 JUP "CTNNG, DP3, DPIII, PDGB, PKGB" ENSG00000173801 "Junction plakoglobin" P14923 17 41754604-41786931 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Cancer-related genes, Cardiomyopathy, Disease mutation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 146.3;skin 1: 126.1;tongue: 122.8" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 335.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 7.6;eosinophil: 14.8;intermediate monocyte: 12.8;memory B-cell: 7.9;myeloid DC: 7.8;naive B-cell: 7.4;non-classical monocyte: 20.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 81.5;OE19: 288.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002139, HPA032047" Supported Supported "Vesicles,Plasma membrane,Cell Junctions" NA NA 61000000 "Plasma membrane, Cell Junctions" Vesicles "CAB002139: AB_563468, HPA032047: AB_2674124" "unprognostic (3.96e-3)" "unprognostic (3.40e-1)" "unprognostic (2.32e-1)" "unprognostic (4.71e-3)" "unprognostic (2.49e-2)" "unprognostic (1.12e-1)" "unprognostic (2.02e-1)" "unprognostic (8.11e-3)" "unprognostic (1.41e-2)" "unprognostic (9.85e-3)" "unprognostic (2.29e-3)" "unprognostic (9.60e-2)" "prognostic favorable (2.06e-10)" "unprognostic (2.50e-1)" "unprognostic (9.49e-2)" "unprognostic (9.05e-2)" "unprognostic (1.51e-2)" 12.5 2.6 2.8 9.5 4.5 3.3 13.0 6.5 3.7 34.5 17.9 8.7 12.3 15.6 12.2 9.6 146.3 13.0 19.0 34.5 3.3 1.6 31.6 11.7 13.2 4.0 5.3 2.2 12.5 12.8 3.6 5.8 42.4 4.0 14.0 8.8 8.3 34.3 14.3 17.6 126.1 36.1 4.3 3.2 4.5 15.4 3.6 4.6 10.8 27.9 122.8 84.8 12.5 55.4 7.9 7.8 14.8 20.6 0.3 0.1 2.9 19.5 16.2 1.6 1.4 0.0 0.0 25.4 1.1 6.7 0.4 0.4 24.6 21.7 0.3 12.1 0.7 0.5 81.5 2.3 18.1 0.0 0.0 5.8 0.8 12.9 5.4 2.7 0.5 8.7 0.0 41.2 0.0 3.3 4.9 7.2 0.5 7.2 7.1 0.0 25.1 0.1 7.0 3.2 288.5 2.7 22.9 0.0 14.6 12.6 50.1 4.0 2.9 2.5 49.5 0.1 7.9 41.3 0.5 11.4 0.0 1.1 0.5 0.3 0.6 2.2 0.3 0.1 0.9 0.1 1.7 7.6 14.8 0.0 12.8 0.0 7.9 0.0 0.1 7.8 7.4 0.1 0.1 0.3 0.3 20.6 2.5 0.0 2.9 2.8 4.5 6.5 3.7 3.3 1.6 5.3 2.2 4.0 4.6 56.6 33.7 8.4 158.6 174.9 1.1 80.3 53.5 18.7 43.3 125.6 3.9 81.5 23.2 189.4 28.7 23.2 158.5 0.0 119.3 141.0 19.6 196.2 10.5 29.3 12.8 0.0 64.1 28.3 5.6 6.4 4.6 9.8 11.8 6.4 91.0 16.2 237.1 128.7 0.0 33.8 4.3 6.5 14.0 2.1 4.2 335.0 155.3 5.1 94.4 236.4 NUMB C14orf41 ENSG00000133961 "NUMB, endocytic adaptor protein" P49757 14 73275107-73458617 "Cancer-related genes, Predicted intracellular proteins" Neurogenesis "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 64.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002874, CAB011478" Approved Enhanced "Cell Junctions" NA NA "Cell Junctions" "CAB011478: AB_443023, HPA002874: " "unprognostic (5.28e-2)" "unprognostic (7.23e-2)" "unprognostic (1.32e-1)" "unprognostic (1.32e-3)" "unprognostic (2.02e-1)" "unprognostic (2.01e-1)" "unprognostic (2.43e-1)" "unprognostic (9.49e-2)" "unprognostic (1.33e-2)" "unprognostic (4.08e-3)" "unprognostic (2.65e-3)" "unprognostic (4.14e-2)" "prognostic favorable (2.32e-6)" "unprognostic (9.12e-2)" "unprognostic (1.63e-1)" "unprognostic (3.92e-2)" "unprognostic (2.87e-1)" 27.3 21.5 26.2 24.5 23.5 21.3 26.4 37.1 27.0 24.2 35.9 17.3 26.1 31.3 30.8 23.9 30.1 28.8 28.8 23.3 23.3 14.1 30.3 35.5 40.5 23.0 18.9 20.7 29.2 26.8 31.8 28.3 29.9 23.4 23.7 29.4 22.3 34.2 23.9 16.4 24.6 45.3 38.0 26.1 32.9 25.1 19.0 19.8 20.1 27.7 17.0 26.2 30.5 26.9 5.2 15.2 64.9 20.9 2.7 3.8 11.6 21.4 14.7 10.6 9.6 21.5 32.9 14.5 20.3 27.5 16.4 17.5 17.7 27.0 9.8 12.8 25.1 12.0 14.2 12.5 20.9 25.0 15.0 7.0 7.8 9.6 11.4 22.9 7.2 18.5 18.3 22.6 40.4 24.2 18.1 35.4 15.5 14.2 11.8 20.7 19.3 13.1 10.0 4.9 24.3 15.8 8.4 14.8 6.6 22.7 32.8 4.4 11.4 25.4 17.2 10.3 18.8 25.8 10.7 33.9 24.7 13.9 15.8 8.7 9.9 11.4 8.9 49.6 8.5 10.8 16.3 19.8 20.8 3.0 17.1 3.1 5.2 3.0 3.3 15.2 5.1 3.1 2.8 64.9 2.7 20.9 2.8 3.8 11.6 26.2 23.5 37.1 27.0 23.3 14.1 18.9 20.7 23.4 19.8 59.6 43.5 56.4 25.1 38.0 28.9 18.3 35.7 45.5 52.4 52.4 76.6 21.2 21.6 24.4 10.3 58.3 51.2 0.0 22.8 25.9 40.1 33.7 23.1 45.1 40.4 14.3 39.1 52.2 90.4 4.6 41.7 93.0 43.9 27.9 35.0 49.3 36.8 39.1 34.6 33.5 48.7 25.8 30.8 38.4 29.8 40.7 28.7 24.9 30.2 40.8 PCDH7 "BH-Pcdh, PPP1R120" ENSG00000169851 "Protocadherin 7" O60245 4 30720415-31146805 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 66.6;Basal keratinocytes: 75.6;Cardiomyocytes: 73.6;Collecting duct cells: 61.1;Urothelial cells: 51.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 16.7;RH-30: 47.0;RT4: 24.8" "Low region specificity" "Detected in all" "HPA011866, HPA046521" Uncertain Enhanced "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "HPA011866: AB_1855047, HPA046521: AB_2679682" "unprognostic (1.87e-1)" "unprognostic (8.88e-2)" "unprognostic (4.48e-2)" "unprognostic (3.32e-1)" "unprognostic (1.38e-1)" "unprognostic (2.45e-1)" "unprognostic (1.04e-2)" "prognostic unfavorable (6.46e-5)" "unprognostic (1.96e-1)" "unprognostic (8.39e-2)" "unprognostic (1.02e-2)" "unprognostic (9.91e-2)" "unprognostic (2.09e-4)" "prognostic unfavorable (6.42e-4)" "unprognostic (1.55e-1)" "unprognostic (7.65e-2)" "unprognostic (1.56e-2)" 2.0 3.2 11.9 4.9 11.5 0.4 3.0 1.2 25.3 23.2 18.4 1.7 34.3 3.1 15.3 22.9 13.0 8.9 7.4 16.7 13.4 11.9 2.2 1.2 2.8 1.4 8.0 11.0 4.5 1.1 0.5 0.8 0.5 11.7 9.9 7.3 6.2 1.6 32.2 0.9 10.1 5.3 23.7 5.3 15.3 14.2 1.2 4.4 0.0 3.9 1.3 1.4 20.1 7.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 5.6 7.8 11.7 11.5 0.0 1.4 0.0 0.7 0.3 0.7 10.2 0.0 0.0 0.0 0.0 5.8 0.5 14.7 1.3 0.0 16.7 0.0 10.6 0.0 12.1 0.2 0.0 6.8 3.4 0.3 4.2 6.9 2.8 0.0 0.0 0.0 3.4 0.0 0.0 0.0 3.4 3.5 1.5 0.0 47.0 0.0 0.3 24.8 0.3 0.1 0.1 0.4 0.5 3.3 0.7 2.6 0.0 9.5 2.4 2.6 0.0 0.0 0.0 0.0 7.4 0.0 6.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 11.5 1.2 24.9 13.4 11.9 8.0 11.0 11.7 4.4 0.0 0.0 0.0 66.6 75.6 29.7 73.6 0.0 13.4 3.4 61.1 0.0 0.1 0.0 0.1 12.1 4.8 0.0 0.0 0.6 0.1 7.7 12.5 1.1 0.0 0.3 9.5 0.0 12.9 0.6 7.9 0.3 0.8 20.3 0.0 0.0 1.3 15.4 0.0 26.9 0.0 2.9 0.0 12.2 1.1 2.4 33.8 0.1 0.0 0.0 51.1 PKP2 ENSG00000057294 "Plakophilin 2" Q99959 12 32790745-32896840 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "heart muscle: 134.7" "Cell type enhanced" "Detected in many" 16 "Cardiomyocytes: 399.9;Extravillous trophoblasts: 148.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 10.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 56.3;OE19: 20.4;SuSa: 45.7" "Region enriched" "Detected in many" 4 "hippocampal formation: 22.1" "Low region specificity" "Detected in all" "HPA014314, CAB037336, HPA056908" Enhanced Enhanced "Nucleoplasm,Cell Junctions" NA NA "Cell Junctions" Nucleoplasm "CAB037336: , HPA014314: AB_1855451, HPA056908: AB_2683272" "unprognostic (1.89e-1)" "unprognostic (1.70e-2)" "prognostic favorable (8.55e-4)" "unprognostic (2.55e-1)" "unprognostic (1.13e-1)" "unprognostic (3.88e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (6.79e-4)" "unprognostic (2.90e-1)" "unprognostic (1.83e-2)" "unprognostic (5.94e-3)" "unprognostic (2.22e-1)" "unprognostic (4.94e-2)" "unprognostic (1.21e-2)" "unprognostic (1.35e-1)" "unprognostic (2.41e-2)" "unprognostic (3.76e-2)" 3.1 0.7 1.4 7.9 5.2 1.1 3.3 2.2 1.8 6.1 14.2 1.4 6.9 6.5 1.2 2.0 3.3 21.6 4.4 134.7 3.9 0.9 3.6 13.6 1.1 3.4 0.7 2.0 9.5 5.4 9.6 14.7 24.1 3.8 3.5 13.3 12.6 24.6 5.0 3.4 1.9 13.3 1.3 1.3 2.4 4.8 3.4 0.4 2.7 0.6 2.3 4.3 2.0 2.1 0.6 3.9 10.4 2.1 1.5 1.0 0.6 15.7 3.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 56.3 14.2 0.0 9.7 0.0 2.1 14.0 1.9 12.4 0.0 0.0 4.5 0.1 0.6 14.7 8.8 0.8 0.2 0.0 11.7 0.0 13.6 6.3 0.5 0.0 2.8 4.4 1.3 4.1 0.0 0.1 8.6 20.4 2.7 0.0 6.8 4.7 4.1 7.5 1.7 1.5 0.6 3.3 0.0 45.7 7.1 0.2 0.1 0.0 6.3 0.0 3.8 3.7 0.0 0.1 0.0 0.0 0.7 5.1 1.4 10.4 0.4 1.6 1.0 0.2 0.6 0.4 3.9 0.6 0.9 0.5 1.2 1.5 2.1 0.8 0.6 0.6 1.4 5.2 2.2 1.8 3.9 0.9 0.7 2.0 3.8 0.4 0.0 0.0 2.4 42.2 6.3 1.0 399.9 15.3 12.0 19.4 1.8 3.9 39.7 3.3 12.2 3.0 3.5 74.7 0.0 8.6 148.3 17.6 16.8 4.6 39.3 7.7 1.6 26.0 3.7 13.1 1.3 10.9 7.4 10.1 0.0 60.1 13.0 16.5 52.6 2.1 8.4 1.1 0.0 1.4 5.4 7.2 2.9 34.7 0.7 87.1 25.7 PKP3 ENSG00000184363 "Plakophilin 3" Q9Y446 11 392614-404908 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 69.0;skin 1: 48.4;tongue: 59.0" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 206.5;Extravillous trophoblasts: 144.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.6;NK-cell: 2.3" "Group enriched" "Detected in many" 5 "NK-cells: 2.3;T-cells: 1.6" "Cell line enhanced" "Detected in many" "A-431: 37.6;CAPAN-2: 26.4;HaCaT: 50.7;hTCEpi: 33.2;MCF7: 23.7;SK-BR-3: 38.5" "Region enriched" "Detected in single" 37 "cerebellum: 10.0" "Low region specificity" "Detected in many" "CAB012993, HPA062937" Enhanced Enhanced "Nucleoplasm,Cell Junctions" NA NA "Cell Junctions" Nucleoplasm "CAB012993: AB_2533221, HPA062937: AB_2684908" "unprognostic (4.74e-2)" "unprognostic (5.28e-2)" "unprognostic (4.45e-2)" "unprognostic (2.25e-2)" "unprognostic (1.58e-2)" "unprognostic (1.57e-1)" "unprognostic (8.88e-3)" "prognostic unfavorable (2.89e-5)" "unprognostic (1.25e-1)" "unprognostic (6.73e-3)" "prognostic unfavorable (3.93e-4)" "unprognostic (3.55e-2)" "prognostic unfavorable (1.08e-4)" "unprognostic (2.16e-2)" "unprognostic (3.41e-1)" "unprognostic (2.60e-1)" "unprognostic (3.15e-2)" 0.6 0.0 0.2 3.7 0.3 0.0 3.3 0.2 0.3 14.5 14.6 0.3 5.0 11.2 1.9 6.2 69.0 2.6 8.9 0.5 0.3 0.1 0.6 0.2 4.3 0.2 0.2 0.2 1.1 10.2 3.9 3.8 23.2 0.2 4.5 3.6 0.2 12.5 2.5 0.6 48.4 25.4 1.0 0.2 0.3 10.4 0.5 0.2 2.2 5.8 59.0 29.9 2.8 21.5 0.3 0.0 0.0 0.0 2.3 1.6 0.1 37.6 7.3 0.0 0.1 0.0 0.0 15.8 0.3 0.2 0.8 0.4 15.0 26.4 0.0 1.5 0.3 1.7 50.7 0.0 19.2 0.1 0.0 9.5 0.0 4.3 10.4 0.1 0.0 0.0 0.1 33.2 0.1 8.1 0.1 0.1 0.0 11.2 0.2 0.1 23.7 0.1 0.0 0.0 19.0 12.7 0.2 0.0 0.1 0.4 7.6 10.8 0.1 10.9 38.5 0.0 0.5 13.9 0.1 1.3 0.2 1.4 0.7 0.2 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.8 0.0 0.3 0.0 0.7 0.0 2.3 0.0 0.0 0.0 0.1 0.2 0.3 0.2 0.3 0.3 0.1 0.2 0.2 0.2 0.2 14.9 15.4 0.0 43.7 64.1 0.0 1.1 7.6 9.4 12.5 12.2 0.0 112.3 0.0 83.2 0.0 0.4 206.5 0.0 54.5 144.7 3.5 34.6 13.8 0.0 11.6 0.0 20.8 0.0 0.0 0.0 0.9 1.8 1.7 3.6 76.4 0.5 96.8 93.0 0.0 0.7 0.1 0.0 1.6 0.0 0.4 77.5 91.8 0.0 83.6 52.6 PKP4 p0071 ENSG00000144283 "Plakophilin 4" Q99569 2 158456964-158682879 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 111.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 5.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037334, HPA066647, HPA070648" Approved Enhanced "Plasma membrane,Cell Junctions" NA NA "Cell Junctions" "Plasma membrane" "CAB037334: , HPA066647: AB_2685696, HPA070648: AB_2686291" "unprognostic (2.76e-1)" "unprognostic (5.26e-2)" "unprognostic (1.48e-2)" "prognostic favorable (5.80e-4)" "unprognostic (2.34e-2)" "unprognostic (1.63e-1)" "unprognostic (1.02e-3)" "unprognostic (2.43e-1)" "unprognostic (1.04e-2)" "unprognostic (9.53e-2)" "unprognostic (1.82e-2)" "unprognostic (9.69e-2)" "prognostic favorable (3.29e-7)" "unprognostic (2.23e-1)" "unprognostic (9.80e-2)" "unprognostic (1.33e-3)" "unprognostic (2.28e-3)" 7.3 3.9 42.7 3.7 42.1 4.2 15.5 14.5 26.6 19.8 7.1 49.9 6.9 7.1 8.3 8.9 10.7 11.8 8.9 12.1 47.7 31.2 34.2 9.7 7.3 3.0 66.9 14.7 8.3 8.7 12.2 6.6 3.4 28.4 7.8 8.1 10.4 19.3 13.1 4.0 9.4 6.4 8.5 111.7 3.2 7.7 5.6 31.6 3.3 18.2 2.4 5.5 9.1 6.9 0.1 0.7 1.0 5.3 0.0 2.1 0.5 16.7 9.3 12.9 14.6 5.9 6.5 12.3 14.0 7.5 21.1 18.3 31.3 15.9 10.7 10.4 16.2 7.7 13.6 16.6 13.9 35.3 16.1 8.5 10.1 10.5 25.5 10.0 16.0 2.2 2.8 13.5 14.5 22.1 12.8 10.6 13.8 13.7 17.1 16.0 18.5 7.0 6.8 13.7 23.4 7.1 9.3 19.2 9.2 31.1 12.1 22.4 4.0 9.7 14.6 11.4 12.4 17.3 14.7 4.9 12.6 14.2 9.3 17.5 9.8 8.2 7.9 7.4 8.8 12.2 0.0 1.0 0.0 0.4 0.3 0.7 0.0 1.5 0.6 0.4 0.1 1.2 0.4 1.0 0.0 5.3 0.7 2.1 0.5 42.7 42.1 14.5 26.6 47.7 31.2 66.9 14.7 28.4 31.6 38.7 17.6 4.9 19.0 24.0 32.4 44.7 50.9 33.5 34.2 45.4 27.5 0.3 19.9 20.4 10.2 56.2 10.3 23.3 15.9 0.3 10.4 28.3 9.3 23.7 2.6 4.8 8.6 20.3 8.1 7.0 10.0 6.7 6.8 1.8 17.6 8.1 14.4 10.5 15.9 25.9 18.6 12.9 13.4 10.7 5.9 26.6 0.2 3.5 19.5 18.6 PLEKHA7 DKFZp686M22243 ENSG00000166689 "Pleckstrin homology domain containing A7" Q6IQ23 11 16777317-17014443 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 23.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "eosinophil: 6.8;MAIT T-cell: 4.5" "Group enriched" "Detected in many" 6 "granulocytes: 6.8;T-cells: 4.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 43.4;HaCaT: 28.7;OE19: 23.8;RT4: 39.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038610, HPA066103" Approved Enhanced "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cell Junctions" Cytosol "HPA038610: AB_10671746, HPA066103: AB_2732738" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "unprognostic (3.81e-2)" "unprognostic (4.30e-2)" "unprognostic (2.51e-2)" "unprognostic (6.95e-3)" "unprognostic (2.81e-2)" "unprognostic (1.85e-2)" "unprognostic (2.65e-1)" "unprognostic (1.73e-1)" "unprognostic (2.65e-3)" "unprognostic (3.13e-2)" "prognostic favorable (1.89e-15)" "unprognostic (9.74e-2)" "unprognostic (1.17e-2)" "unprognostic (4.81e-1)" "unprognostic (2.65e-2)" 6.8 1.2 5.3 6.6 8.0 0.1 10.7 2.9 4.9 7.7 18.1 10.9 10.0 17.7 4.7 6.0 30.6 6.0 15.1 13.6 7.5 4.2 18.1 9.0 6.4 1.2 7.2 4.6 8.1 18.9 19.1 3.2 18.7 14.5 6.0 11.5 18.2 15.0 16.3 2.7 8.9 32.0 2.7 8.1 1.7 15.2 7.4 7.9 1.4 7.2 1.9 5.5 10.7 12.4 0.5 0.9 6.8 0.3 0.2 4.5 0.3 5.1 4.6 4.9 2.2 0.2 0.0 8.1 0.0 0.1 1.7 3.2 7.9 43.4 0.0 2.0 0.6 0.2 28.7 6.5 0.0 1.2 1.5 6.3 13.3 3.7 5.4 0.1 0.0 0.1 0.2 2.5 0.0 0.1 4.0 0.0 5.6 0.5 0.1 0.7 3.3 3.0 0.1 2.7 23.8 4.5 4.1 0.0 1.0 4.2 39.3 3.1 0.3 5.9 16.9 0.2 9.3 4.3 1.5 1.1 0.0 1.6 1.2 1.0 2.9 0.9 5.8 0.0 0.2 0.0 0.2 0.3 6.8 0.6 0.1 4.5 0.5 0.8 0.6 0.3 0.2 0.2 0.4 0.6 0.2 0.1 0.9 0.1 0.3 5.3 8.0 2.9 4.9 7.5 4.2 7.2 4.6 14.5 7.9 3.0 13.4 0.0 1.2 0.6 1.2 8.7 5.1 6.7 12.5 10.4 23.6 5.4 3.3 4.7 11.7 2.3 8.4 0.0 5.3 0.8 0.6 0.8 2.3 2.4 1.7 0.0 0.0 0.6 1.0 4.5 0.6 2.4 0.0 1.0 4.6 3.9 7.6 3.5 0.4 8.1 10.6 0.0 0.3 0.2 0.5 0.4 5.0 0.5 2.6 4.6 SCRIB "KIAA0147, SCRB1, Vartul" ENSG00000180900 "Scribbled planar cell polarity protein" Q14160 8 143790920-143815379 "Disease related genes, Predicted intracellular proteins" "Differentiation, Host-virus interaction, Inhibition of host innate immune response by virus, Inhibition of host interferon signaling pathway by virus, Inhibition of host STAT1 by virus, Inhibition of host STAT2 by virus, Viral immunoevasion" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015463, CAB022081, HPA023557, HPA064312" Supported Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions,Rods & Rings" NA NA "Plasma membrane, Cell Junctions" "Nucleoplasm, Rods & Rings" "CAB015463: AB_2238926, CAB022081: , HPA023557: AB_2671238, HPA064312: AB_2685242" "unprognostic (1.24e-1)" "unprognostic (1.94e-2)" "unprognostic (7.78e-2)" "unprognostic (8.95e-2)" "unprognostic (3.77e-1)" "unprognostic (3.96e-2)" "unprognostic (1.14e-3)" "unprognostic (1.86e-2)" "unprognostic (2.46e-1)" "unprognostic (2.56e-1)" "unprognostic (8.22e-2)" "unprognostic (1.87e-1)" "unprognostic (2.16e-3)" "unprognostic (3.46e-3)" "unprognostic (1.99e-1)" "unprognostic (1.10e-1)" "unprognostic (1.83e-1)" 13.0 6.1 15.1 10.8 12.2 9.4 15.9 10.1 13.9 15.1 18.4 17.5 9.8 14.8 9.4 5.9 36.6 11.6 11.9 8.0 12.2 7.7 10.2 13.6 11.5 12.9 13.5 12.8 10.9 17.2 11.2 9.6 9.5 11.8 10.9 7.6 7.5 22.9 11.2 36.8 33.3 16.3 11.2 9.7 11.2 17.0 10.1 16.4 14.0 9.1 11.9 9.6 11.6 17.8 0.6 0.5 0.2 0.4 0.2 1.5 0.6 18.6 15.1 6.9 8.8 2.5 3.3 11.7 10.5 3.0 4.9 4.1 6.6 12.2 7.4 12.8 3.1 2.8 19.5 3.7 14.1 0.9 8.2 20.8 10.3 13.0 11.6 5.7 4.3 5.8 2.8 13.7 4.7 4.1 2.2 5.3 8.1 13.0 2.6 3.7 37.2 11.1 9.2 5.2 11.6 19.2 13.4 6.4 8.2 2.5 18.8 15.1 11.1 11.9 13.1 11.1 2.2 16.5 10.3 10.2 5.4 22.4 9.5 14.7 9.3 9.1 7.5 5.5 4.3 8.4 0.1 0.1 0.1 0.6 0.4 1.5 0.6 0.4 1.2 0.5 0.4 0.4 0.4 0.2 0.2 0.1 0.2 0.4 0.6 15.1 12.2 10.1 13.9 12.2 7.7 13.5 12.8 11.8 16.4 0.0 6.9 6.9 4.2 7.6 11.1 10.8 15.3 1.4 1.2 14.0 13.7 8.9 3.3 7.5 1.2 6.0 18.4 23.3 8.1 5.3 5.1 8.0 0.0 7.5 5.5 4.8 13.3 4.3 6.3 0.4 8.3 4.6 8.5 4.6 19.5 11.9 9.9 20.1 9.2 4.3 14.0 12.9 4.2 7.9 9.2 9.4 4.2 5.1 19.5 5.9 SLC16A1 "MCT, MCT1" ENSG00000155380 "Solute carrier family 16 member 1" P53985 1 112911847-112957013 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 149.2;Muller glia cells: 221.8;Rod photoreceptor cells: 246.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003324, CAB017489, HPA071055, CAB079035" Enhanced Supported Enhanced "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "CAB017489: AB_2189197, CAB079035: , HPA003324: AB_1856982, HPA071055: AB_2686337" "unprognostic (1.19e-1)" "unprognostic (1.61e-2)" "unprognostic (2.97e-1)" "prognostic unfavorable (8.37e-6)" "unprognostic (1.53e-1)" "unprognostic (2.89e-2)" "unprognostic (2.15e-3)" "prognostic unfavorable (4.05e-4)" "unprognostic (6.92e-2)" "unprognostic (6.31e-3)" "prognostic unfavorable (2.10e-4)" "unprognostic (1.18e-1)" "prognostic unfavorable (6.78e-8)" "unprognostic (1.30e-1)" "unprognostic (2.31e-1)" "unprognostic (1.04e-2)" "unprognostic (1.53e-3)" 11.6 7.2 17.4 8.7 19.5 3.1 4.4 10.0 24.0 4.6 23.4 12.7 3.3 18.4 19.3 15.1 10.4 8.7 8.3 39.0 19.5 12.3 6.5 26.9 3.2 5.8 19.2 6.5 6.0 1.9 5.6 3.7 18.8 16.6 8.3 18.1 22.8 2.5 6.5 31.4 7.5 9.5 20.0 16.1 4.8 14.5 17.9 22.5 4.9 5.4 17.7 6.2 9.6 6.2 3.0 5.9 0.6 3.2 2.0 11.4 2.4 20.2 4.7 14.6 12.4 10.1 8.6 48.0 10.9 8.3 8.6 13.9 16.0 11.8 22.2 15.3 9.9 6.4 19.4 20.4 20.3 16.3 13.9 20.7 18.2 12.9 18.6 17.9 23.2 1.9 12.0 24.9 12.7 25.0 13.9 20.8 11.6 23.0 14.8 9.6 3.9 13.6 11.7 47.2 5.6 15.2 12.2 23.0 15.3 10.6 0.4 16.2 8.5 21.2 0.6 16.2 21.9 0.9 8.8 14.0 8.3 14.6 16.3 16.1 7.8 6.8 22.4 24.1 14.7 10.2 0.6 3.2 0.0 4.1 2.6 6.3 3.0 4.1 4.4 5.9 2.1 4.4 3.8 0.3 2.0 0.7 1.0 11.4 2.4 17.4 19.5 10.0 24.0 19.5 12.3 19.2 6.5 16.6 22.5 0.0 1.6 15.2 6.7 79.3 17.1 109.7 5.1 0.0 1.2 0.0 149.2 57.9 0.0 2.0 102.1 20.4 27.6 0.0 2.9 62.5 30.5 13.5 9.2 34.7 13.7 19.1 3.4 8.0 9.1 75.6 10.9 4.8 37.1 1.8 14.9 221.8 5.1 5.7 7.1 10.2 246.9 0.0 20.6 35.1 10.2 34.5 38.4 6.9 13.6 0.9 TIAM1 ENSG00000156299 "T cell lymphoma invasion and metastasis 1" Q13009 21 31118416-31559977 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 110.1" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 74.4;Horizontal cells: 69.9;Suprabasal keratinocytes: 125.3;Urothelial cells: 72.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 8 "cerebellum: 110.1" "Group enriched" "Detected in many" 5 "classical monocyte: 10.7;intermediate monocyte: 9.6;memory CD4 T-cell: 8.3;myeloid DC: 5.9;naive CD4 T-cell: 10.9;NK-cell: 6.9;non-classical monocyte: 12.4;T-reg: 16.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 19.4;HEL: 18.7;HMC-1: 16.4;RT4: 19.4;SCLC-21H: 18.3" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 574.6" "CAB010416, HPA034853" Enhanced Supported "Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol" NA NA "Nucleoplasm, Cell Junctions" "Nuclear membrane, Cytokinetic bridge, Cytosol" "CAB010416: AB_2240410, HPA034853: " "unprognostic (9.59e-2)" "unprognostic (7.44e-3)" "unprognostic (5.64e-3)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (2.81e-3)" "unprognostic (2.84e-2)" "unprognostic (3.73e-1)" "unprognostic (8.08e-2)" "unprognostic (2.70e-3)" "unprognostic (7.97e-3)" "unprognostic (9.52e-2)" "unprognostic (1.20e-3)" "unprognostic (2.38e-3)" "unprognostic (1.61e-1)" "unprognostic (1.04e-2)" "unprognostic (2.21e-1)" 3.3 11.4 13.4 5.3 12.4 2.1 4.4 110.1 15.1 10.1 2.2 9.7 0.5 1.5 7.9 3.0 18.9 9.4 4.0 2.1 11.6 7.0 1.7 3.7 4.1 8.8 6.2 7.9 1.5 1.9 0.3 4.2 4.4 8.9 3.7 2.8 7.0 2.2 3.1 0.7 20.4 1.7 10.0 6.4 4.2 2.1 5.9 7.1 6.2 1.3 5.3 9.3 8.1 5.0 0.1 5.9 0.6 12.4 6.9 16.8 3.6 1.5 0.5 12.1 0.7 0.2 2.8 19.4 0.0 0.0 1.5 0.5 0.1 2.2 4.1 0.8 0.3 2.2 2.8 1.4 2.4 2.4 0.3 6.7 18.7 0.3 0.1 0.3 0.0 16.4 1.2 0.8 8.2 3.3 1.4 0.0 6.2 0.0 6.1 6.1 7.9 2.8 0.1 3.9 2.9 5.2 3.7 3.8 0.0 1.8 19.4 18.3 4.5 0.8 6.3 0.7 4.4 2.6 0.0 0.1 1.7 7.1 0.0 0.8 6.9 5.1 3.7 4.0 1.4 13.4 0.6 10.7 0.0 0.3 9.6 2.1 0.1 8.3 1.6 5.9 0.0 10.9 0.6 0.6 6.9 12.4 0.3 16.8 3.6 13.4 12.4 110.1 14.4 11.6 7.0 6.2 7.9 8.9 7.1 3.0 2.9 0.8 40.5 74.4 1.2 1.1 2.5 0.0 18.2 0.0 2.0 7.6 0.0 1.5 10.0 15.8 0.0 0.0 0.6 25.1 7.6 16.1 23.1 3.6 8.2 69.9 5.2 50.3 22.7 9.0 31.9 28.4 10.1 18.0 0.3 39.3 1.1 10.7 54.8 0.0 4.4 6.5 2.1 1.4 6.1 125.3 8.9 6.9 0.9 72.7 TJP1 "DKFZp686M05161, MGC133289, ZO-1" ENSG00000104067 "Tight junction protein 1" Q07157 15 29699367-29968865 "Predicted intracellular proteins, Transporters" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001636, HPA001637, CAB010822" Enhanced Enhanced "Cell Junctions" NA NA "Cell Junctions" "CAB010822: , HPA001636: AB_1080762, HPA001637: AB_1080760" "unprognostic (2.11e-2)" "unprognostic (6.83e-2)" "unprognostic (1.21e-1)" "unprognostic (2.81e-2)" "unprognostic (9.43e-2)" "unprognostic (1.21e-1)" "unprognostic (4.54e-2)" "unprognostic (6.71e-3)" "unprognostic (1.98e-1)" "unprognostic (2.86e-1)" "unprognostic (2.86e-3)" "unprognostic (3.54e-1)" "prognostic favorable (1.72e-4)" "unprognostic (2.85e-3)" "unprognostic (3.02e-1)" "unprognostic (5.04e-2)" "unprognostic (1.20e-1)" 22.1 11.7 27.5 9.2 32.8 2.2 18.0 12.0 36.3 24.8 16.9 37.5 10.7 10.9 29.5 27.6 45.7 22.9 18.2 26.0 28.3 19.1 20.4 20.8 31.1 7.8 29.3 21.3 23.6 19.4 30.1 17.7 38.3 23.4 17.8 15.5 15.2 18.5 15.4 16.4 17.8 14.4 29.4 31.7 10.1 16.7 25.9 32.6 1.2 23.1 17.9 13.2 18.5 27.3 0.7 0.2 0.3 0.4 1.0 0.2 0.1 26.1 19.3 10.6 8.7 9.4 13.1 12.0 8.1 7.2 6.8 7.7 26.6 10.5 0.1 11.0 10.8 9.0 19.7 6.5 9.1 8.7 0.2 7.2 0.1 10.4 11.2 25.3 0.0 0.3 7.2 6.6 8.4 16.3 10.4 15.1 0.0 9.7 5.4 5.2 14.5 0.1 0.2 9.7 11.9 6.1 0.0 15.0 0.0 13.6 16.1 5.2 7.4 16.7 7.3 6.9 21.9 5.0 0.3 23.6 7.0 10.7 4.8 11.1 1.9 1.8 0.1 7.9 0.1 3.9 0.0 0.2 0.1 0.0 0.1 0.0 0.4 0.1 0.1 0.0 0.7 0.2 0.2 0.3 1.0 0.4 0.2 0.2 0.1 27.5 32.8 12.0 26.1 28.3 19.1 29.3 21.3 23.4 32.6 157.8 42.2 2.2 89.8 31.8 36.2 95.8 38.2 29.4 43.3 55.8 9.8 24.8 21.6 107.0 12.1 131.3 49.5 0.0 72.9 11.2 45.0 132.7 5.7 41.4 3.3 119.2 44.1 93.3 8.4 9.4 31.4 5.7 60.8 2.8 31.6 34.9 126.3 31.5 60.1 20.9 49.7 77.6 86.8 53.9 47.9 52.6 28.1 4.4 19.1 142.6 TJP2 "DFNA51, X104, ZO-2, ZO2" ENSG00000119139 "Tight junction protein 2" Q9UDY2 9 69121264-69255208 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 241.2;Rod photoreceptor cells: 273.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 4.0" "Lineage enriched" "Detected in single" 8 "monocytes: 4.0" "Cell line enhanced" "Detected in many" "A-431: 53.3" "HPA001813, CAB009228, HPA070714" Supported Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA 790000 "Plasma membrane, Cell Junctions" Nucleoplasm "CAB009228: AB_2203583, HPA001813: AB_1080764, HPA070714: AB_2732161" "unprognostic (1.30e-1)" "unprognostic (7.69e-2)" "unprognostic (1.23e-3)" "unprognostic (7.68e-2)" "unprognostic (2.01e-1)" "unprognostic (8.83e-3)" "unprognostic (1.94e-2)" "unprognostic (1.86e-1)" "unprognostic (4.82e-2)" "unprognostic (3.30e-2)" "unprognostic (2.93e-3)" "unprognostic (3.60e-1)" "prognostic favorable (1.78e-14)" "unprognostic (3.29e-2)" "unprognostic (6.42e-2)" "unprognostic (8.15e-3)" "unprognostic (5.85e-2)" 25.2 9.5 23.7 8.0 29.7 5.7 20.7 35.6 24.9 9.0 20.0 50.3 20.6 27.2 11.9 7.3 28.9 12.6 13.2 19.8 35.1 12.7 23.3 34.5 23.9 5.8 39.7 20.5 20.9 13.2 43.2 3.6 18.0 32.0 13.5 16.7 19.1 18.0 23.1 8.3 18.6 25.7 15.3 39.7 3.5 30.4 17.8 41.1 11.1 22.5 9.0 10.8 26.5 26.6 0.0 0.2 0.4 4.0 0.0 0.5 0.5 53.3 1.7 4.3 4.8 20.1 19.7 23.3 8.1 6.0 13.0 7.1 6.5 19.5 7.7 8.1 4.5 7.0 32.9 6.9 17.1 14.8 27.3 5.0 7.4 4.6 32.9 5.7 3.0 14.1 15.3 12.3 10.1 6.1 3.7 27.2 2.1 4.5 5.2 6.8 7.5 1.1 0.4 10.4 33.4 11.7 3.9 6.1 0.8 33.4 35.6 1.9 3.3 2.9 20.8 0.6 9.9 6.7 1.6 39.0 9.7 10.5 7.5 8.3 5.4 1.1 0.1 11.2 4.3 3.6 0.0 0.7 0.0 0.0 1.5 0.4 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.4 0.0 4.0 0.1 0.5 0.5 23.7 29.7 35.6 17.5 35.1 12.7 39.7 20.5 32.0 41.1 41.7 21.4 1.4 65.1 57.9 241.2 34.6 50.9 9.4 5.7 3.5 33.4 24.0 0.0 27.8 2.7 42.7 67.5 0.0 20.8 23.1 14.7 83.3 5.7 92.7 4.9 17.5 11.1 25.2 17.0 3.6 27.0 2.8 27.0 4.6 41.5 123.0 32.6 42.5 13.1 1.4 273.3 0.0 10.3 21.3 11.1 56.0 36.2 3.1 36.2 146.9 TJP3 ZO-3 ENSG00000105289 "Tight junction protein 3" O95049 19 3708109-3750813 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 47.0" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 259.3;Enterocytes: 138.3;Paneth cells: 101.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 4 "gdT-cell: 2.0;MAIT T-cell: 6.2;memory CD4 T-cell: 4.8;memory CD8 T-cell: 3.8;naive CD4 T-cell: 5.3;naive CD8 T-cell: 1.9;T-reg: 5.5" "Lineage enriched" "Detected in many" 6 "T-cells: 6.2" "Cell line enhanced" "Detected in some" "BEWO: 22.2;CAPAN-2: 22.3;MCF7: 9.8;OE19: 17.4;SK-BR-3: 13.0;T-47d: 27.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB013244, HPA046863, HPA053337" Enhanced Enhanced "Nucleoplasm,Cell Junctions" NA NA "Nucleoplasm, Cell Junctions" "CAB013244: AB_2533257, HPA046863: AB_2679845, HPA053337: AB_2682118" "unprognostic (2.22e-1)" "unprognostic (1.39e-1)" "unprognostic (2.80e-1)" "prognostic favorable (1.83e-6)" "unprognostic (2.78e-1)" "prognostic favorable (9.52e-4)" "unprognostic (1.30e-1)" "unprognostic (1.25e-1)" "unprognostic (2.52e-1)" "unprognostic (6.52e-2)" "unprognostic (2.15e-2)" "unprognostic (1.78e-1)" "prognostic favorable (9.36e-8)" "unprognostic (8.58e-3)" "unprognostic (5.03e-2)" "unprognostic (1.31e-1)" "unprognostic (4.62e-3)" 0.2 0.0 0.3 8.4 0.4 0.0 3.6 0.2 0.3 3.3 34.9 0.7 15.0 23.0 0.7 5.0 16.0 7.9 22.8 0.6 0.5 0.1 4.4 8.0 10.1 0.6 0.2 0.2 2.2 5.9 2.0 1.6 2.7 1.1 2.6 7.7 1.6 26.1 20.5 0.4 4.3 47.0 0.6 0.2 0.4 15.2 1.4 0.2 0.6 5.5 2.6 8.3 4.5 3.4 1.0 0.0 0.0 0.0 0.0 6.2 1.7 0.1 3.3 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.0 0.0 6.5 22.3 4.0 0.6 0.0 0.0 5.2 0.3 0.0 0.0 0.2 0.1 0.0 0.5 1.6 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 9.8 0.0 0.1 0.4 17.4 0.1 0.0 0.0 2.9 0.7 3.4 0.1 0.1 0.8 13.0 0.0 1.7 27.4 0.1 0.0 0.0 0.5 0.0 0.0 0.8 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.0 6.2 0.7 4.8 3.8 0.0 1.0 5.3 1.9 0.0 0.0 0.0 0.0 5.5 1.7 0.3 0.4 0.2 0.3 0.5 0.1 0.2 0.2 1.1 0.2 8.9 10.7 0.0 6.7 0.0 0.0 0.8 30.6 34.8 12.5 29.6 0.0 26.9 16.6 16.8 259.3 0.0 138.3 0.0 21.0 3.5 0.2 4.8 4.6 4.9 2.4 0.0 12.0 0.0 0.0 10.7 1.7 0.1 3.3 0.0 40.6 0.0 16.7 101.7 1.1 5.1 0.0 0.0 0.2 2.1 3.3 0.1 33.6 1.5 46.1 23.1 TP53BP2 "53BP2, ASPP2, PPP1R13A" ENSG00000143514 "Tumor protein p53 binding protein 2" Q13625 1 223779899-223845972 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021603, HPA050429" Supported Enhanced "Cell Junctions,Cytosol" NA NA "Cell Junctions, Cytosol" "HPA021603: AB_1844384, HPA050429: AB_2681124" "unprognostic (1.29e-1)" "unprognostic (5.11e-2)" "unprognostic (3.24e-1)" "unprognostic (1.38e-3)" "unprognostic (1.24e-1)" "unprognostic (1.03e-1)" "unprognostic (7.65e-2)" "unprognostic (1.93e-1)" "unprognostic (1.66e-1)" "unprognostic (1.48e-2)" "unprognostic (7.37e-2)" "unprognostic (2.67e-1)" "unprognostic (7.99e-2)" "unprognostic (5.08e-2)" "unprognostic (1.24e-1)" "unprognostic (2.81e-2)" "unprognostic (1.83e-1)" 10.0 8.3 26.5 17.2 28.7 38.8 20.8 9.3 17.9 10.9 12.0 12.6 8.1 7.9 11.9 9.8 15.9 9.4 17.4 10.9 17.3 14.7 10.1 13.9 21.4 18.6 18.7 8.6 15.5 13.0 16.4 8.3 8.2 12.9 9.6 9.5 17.7 10.2 8.1 12.0 9.9 9.5 12.2 13.0 10.6 9.7 10.2 14.9 17.3 22.1 7.4 11.7 11.8 14.8 2.2 2.9 6.7 2.7 7.2 4.0 2.0 15.6 7.9 21.4 13.5 7.6 7.5 13.7 10.1 14.4 14.8 12.7 16.3 9.5 0.0 8.9 8.4 10.7 10.7 16.7 6.0 19.9 30.2 16.4 20.8 7.6 5.5 15.5 17.1 14.6 8.9 6.7 13.6 14.0 11.1 8.7 11.6 26.3 15.8 12.2 4.5 12.9 10.6 18.5 9.5 7.7 17.2 22.3 1.7 13.3 9.9 18.6 24.0 11.1 13.9 14.6 14.7 7.8 23.5 10.1 15.2 10.8 16.3 18.9 7.8 8.1 13.0 9.2 11.5 17.3 6.7 2.7 1.6 2.3 2.6 2.8 2.2 2.6 4.0 2.9 1.9 2.7 1.9 3.2 7.2 2.0 1.7 1.6 2.0 26.5 28.7 9.3 17.9 17.3 14.7 18.7 8.6 12.9 14.9 44.7 24.3 6.5 41.6 15.2 4.4 15.4 12.7 17.4 42.1 7.0 49.1 9.1 1.7 18.3 0.9 10.9 9.1 23.3 9.3 5.0 17.9 31.4 47.4 9.7 8.6 0.0 14.3 10.4 14.8 1.4 9.8 15.0 8.5 6.4 7.9 6.9 17.8 5.8 8.1 4.4 45.8 0.0 20.8 11.4 22.2 10.2 4.0 10.9 9.8 38.8